How the sprint for a coronavirus vaccine transformed Moderna into a $39 billion powerhouse that’s poised to reshape biotech

Summary List Placement In January, Stéphane Bancel, the chief executive of Moderna, was skimming through the news on his iPad while vacationing with his family in the south of France. A headline stopped his finger: “Health Officials Work to Solve China’s Mystery Virus Outbreak,” The Wall Street Journal reported on January 6. The Frenchman, who…

Read more